Householder Group Estate & Retirement Specialist’s Definium Therapeutics DFTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-600
Closed -$2K 1302
2023
Q4
$2K Buy
600
+300
+100% +$903 ﹤0.01% 1002
2023
Q3
$939 Buy
+300
New +$1.23K ﹤0.01% 1147

Other funds holding DFTX

Householder Group Estate & Retirement Specialist's DFTX Position: Q1 2024 in Review

Householder Group Estate & Retirement Specialist sold out of Definium Therapeutics (DFTX) in Q1 2024, closing a stake of 600 shares — an estimated $2K sold.

Householder Group Estate & Retirement Specialist first reported a position in DFTX in Q3 2023 and held it in 2 quarters. The position peaked at $2K in Q4 2023. 135 funds tracked by Wall St. Rank hold DFTX as of Q1 2024.

  • Householder Group Estate & Retirement Specialist reported no remaining Definium Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Householder Group Estate & Retirement Specialist sold 600 Definium Therapeutics shares in Q1 2024, an estimated $2K.
  • Householder Group Estate & Retirement Specialist first reported a position in Definium Therapeutics in Q3 2023 and held it in 2 quarters.
  • Householder Group Estate & Retirement Specialist's Definium Therapeutics position peaked at $2K in Q4 2023.
  • 135 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2024.

Based on Householder Group Estate & Retirement Specialist's 13F filing for Q1 2024, filed 3 May 2024.